HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    

Profit from the Pros – Zacks Free Email Newsletter
Our free email newsletter is filled with timely stock picks and market commentary. Sign up for free. Already on board? Check out the archive.
Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Top 10 Stocks
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive

DNDN: Dendreon Cp - Stock News Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Company News |  Zacks Commentary
DENDREON CP (NASD)
DNDN 27.54 0.00 (0.00%) Vol.  600 0.00 CST

Nov 23, 2009 BiomedReports: News and FDA Updates for OPTIMIZERx (OTC:OPRX), Dendreon (Nasdaq:DNDN), Ligand (NASDAQ:LGND)
Nov 20, 2009 xtremepicks.com: www.Xtremepicks.Com: Xtremepicks Alerts November 20, 2009 : DNDN, POZN, VCLK and NUAN
Nov 20, 2009 Dendreon Receives FDA Acknowledgement of Complete Response
Nov 12, 2009 BUYINS.NET: Dendreon (DNDN) Down After BUYINS.NET Report Predicted Weakness After Earnings
Nov 11, 2009 Dendreon Reports Third Quarter 2009 Financial Results and Continuing Progress Toward PROVENGE Commercialization
Nov 09, 2009 BUYINS.NET: M, DNDN, GRRF, APU, UBET, ALLT Expected To Be Lower After Earnings Releases on Wednesday
Nov 03, 2009 BiomedReports: News and FDA Updates for Gilead (Nasdaq:GILD), Dendreon (Nasdaq:DNDN), Phase Forward (NASDAQ:PFWD)
Nov 03, 2009 BenchmarkJournal.com Issues Independent Review on FINL, FSLR, EWBC,FITB, BARE and DNDN
Nov 02, 2009 StockProfiler.US: Stock Watch: LABL, DNDN, VSPC
Nov 02, 2009 MONSTERSTOX.COM: Monsterstox.com : Dendreon Corporation (Nasdaq: DNDN)
Nov 02, 2009 Dendreon Completes Submission of Biologics License Application for PROVENGE
Oct 30, 2009 Dendreon to Hold Conference Call on Wednesday, November 11, 2009 at 4:30 PM ET
Oct 29, 2009 www.StockMarketingInc.com: SKTO aEUR" SK3 Group, Inc. "LATEST NEWS!! SK3 Group Signs Joint Venture With Chiropractic USA Inc." Our Subscribers Profit!! Sign Up Now!!
Oct 29, 2009 Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
Oct 20, 2009 Mentor Capital Cancer Immunotherapy Index Improves at a 320% Annualized Rate for Quarter
 
ZACKS COMMENTARY FOR DNDN
Nov 12, 2009 Zacks Equity Research: Report for DNDN
Oct 09, 2009 Zacks Blog: Dendreon to Seek FDA Approval
Sep 28, 2009 Zacks Blog: Dendreon Awaits Provenge Approval
Aug 17, 2009 Zacks Blog: Wider Loss for Dendreon
Jul 07, 2009 Zacks Blog: Dendreon Raising Money
Jun 01, 2009 Zacks Blog: Zacks Industry Outlook Highlights: Myriad Genetics, Onyx Pharmaceuticals Inc., AMAG Pharmaceuticals Inc., Dendreon and 3SBio Inc.
Jun 01, 2009 Zacks Analyst Interviews: Biotech Industry
May 29, 2009 Zacks Blog: Biotech Industry
Apr 29, 2009 Zacks Blog: DNDN Study Removes Uncertainty
Apr 29, 2009 Zacks Blog: Company News for April 29, 2009
Apr 15, 2009 Zacks Blog: Dendreon, MBIA, Goldman Sachs, JP Morgan Chase and Bank of America
Apr 15, 2009 Bull of the Day: Dendreon Corp. (DNDN)

 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2009 Zacks Investment Research